We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Atomo Diagnostics

Atomo Diagnostics Limited supplies unique, integrated rapid diagnostic test (RDT) devices and finished point-of-care ... read more Featured Products: More products

Download Mobile App





Atomo Diagnostics Showcases Innovative User-Centered Rapid Diagnostic Tests at Arab Health

By HospiMedica International staff writers
Posted on 29 Jan 2023
Print article
Image: The innovative user-centered rapid diagnostic tests are simpler to use than standard multi-component test kits (Photo courtesy of Atomo Diagnostics)
Image: The innovative user-centered rapid diagnostic tests are simpler to use than standard multi-component test kits (Photo courtesy of Atomo Diagnostics)

Atomo Diagnostics (Sydney, Australia) is showcasing its range of innovative, user-centered rapid diagnostic test platforms at Arab Health 2023. The Arab Health Exhibition & Congress is taking place from 30 January – 2 February 2023 at the Dubai Convention and Exhibition Center. Atomo is part of the ABHI UK Pavilion where it is demonstrating how the company’s simple and low-cost solutions can deliver better user experience, more accurate results and better healthcare outcomes.

Atomo is the world’s first company to introduce human-centered engineering to the heart of diagnostics design. The company has developed a unique technology based on the philosophy that fast, accurate point of care testing should be simple and intuitive, focusing on how diagnostic tests operate in the hands of users to improve ease of use and reduce error rates. Atomo has created devices that address the problems commonly associated with standard multi-component rapid diagnostic test kits that have also received several international design awards.

Atomo’s Rapid Diagnostic Test (RDT) platforms offer all-in-one convenience with a built-in safety lancet, unique sample collection feature, single action sample and buffer delivery system, and interlocked user steps. The innovative design and built-in features of Atomo’s products are designed to make them simpler to use than standard multi-component test kits, with less scope for user errors. The company offers the world’s first integrated, blood-based rapid diagnostic test (RDT) for HIV screening, recognized globally for its design, performance and ease-of-use, with an accuracy of 99.6%.

Atomo’s extensive product range also encompasses accurate point of care diagnostic platforms that can be used in testing for infectious diseases such as COVID-19, allergy sensitivities, wellness, women’s health, men’s health, sexual health, heart health and other applications. Atomo recently introduced a Swab Platform to market, which expands its product range beyond blood-based testing and has been developed to improve usability and performance of traditional swab-based rapid tests. The company’s products are approved for distribution in over 40 countries.

“Our innovative rapid test solutions deliver unmatched usability and simplicity in point-of-care testing, and have demonstrated excellent performance for both professional and home use. Our flagship HIV Self Test is prequalified by the WHO and registered in more than 20 countries. Beyond HIV, Atomo works with partners to commercialize tests on its devices for other applications, with commercialized tests delivering early detection of pregnancy and differentiating between viral and bacterial infection in primary care settings,” said John Kelly, CEO of Atomo Diagnostics. “Our unique devices and functionality are increasingly being recognized as a solution to decentralized testing needs and we continue to seek partners looking to improve the usability and performance of their POC tests. We are excited to be joining ABHI at this year’s Arab Health Exhibition where we look forward to showcasing our innovative products and technologies, as well as making new connections and forming new partnerships with global distributors.”

Related Links:
Atomo Diagnostics

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Neonatal Transport Ventilator
Babylite

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.